When:
April 19, 2017 @ 5:30 pm – 7:30 pm
2017-04-19T17:30:00-04:00
2017-04-19T19:30:00-04:00
Where:
Alexion Pharmaceuticals
100 College St
New Haven, CT 06510
USA

Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.

The series will launch Sept. 19-21 followed by monthly scheduled workshops, all hosted at Alexion. The series will bring in investors, biotech entrepre­neurs, legal experts and others to provide guidance, hands-on workshops and case studies on topics like business plans and funding for life science companies; intellectual property and regulatory considerations; marketing; case studies in life science entrepreneurship; FDA approval; trends in life science funding and exits and more.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

Schedule:

MON., SEPT. 19, 5:30-7:30pm: “Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies” with Colleen Cuffaro, Associate at Canaan Partners.Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.

TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.

WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include:Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.

OTHER DATES:

October 19, 5:30-7:30pm: Case Studies in Life Science Entrepreneurship

November 16, 5:30-7:30pm: Tech Transfer – IP & Licensing

December 12, 5:30-7:30pm (Please note Monday!): FDA Approval and Regulatory Issues

January 25, 5:30-7:30pm: Trends in Life Science Funding & Exits, Corporate Strategy & Business Development

February 15, 5:30-7:30pm: Payors & Reimbursement

April 19, 5:30-7:30pm: Medical Devices/Diagnostics & Health IT